| Product NDC: | 17478-892 |
| Proprietary Name: | Diclofenac |
| Non Proprietary Name: | Diclofenac Sodium |
| Active Ingredient(s): | 1 mg/mL & nbsp; Diclofenac Sodium |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 17478-892 |
| Labeler Name: | Akorn, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077845 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080501 |
| Package NDC: | 17478-892-25 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (17478-892-25) > 2.5 mL in 1 BOTTLE, DROPPER |
| NDC Code | 17478-892-25 |
| Proprietary Name | Diclofenac |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (17478-892-25) > 2.5 mL in 1 BOTTLE, DROPPER |
| Product NDC | 17478-892 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Diclofenac Sodium |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20080501 |
| Marketing Category Name | ANDA |
| Labeler Name | Akorn, Inc. |
| Substance Name | DICLOFENAC SODIUM |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |